• norsk
    • English
  • English 
    • norsk
    • English
  • Login
Browsing by Author 
  •   Home
  • Browsing by Author
  •   Home
  • Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.

Browsing NTNU Open by Author "Halvorsen, Sigrun"

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Æ
  • Ø
  • Å

Sort by:

Order:

Results:

Now showing items 1-3 of 3

  • title
  • issue date
  • submit date
  • author
  • ascending
  • descending
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study 

      Rutherford, Ole-Christian Walter; Jonasson, Christian; Ghanima, Waleed Khalid; Halvorsen, Sigrun (Peer reviewed; Journal article, 2020)
      The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and apixaban in routine clinical practice. Methods ...
    • New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs 

      Rutherford, Ole-Christian Walter; Jonasson, Christian; Ghanima, Waleed Khalid; Holst, René; Halvorsen, Sigrun (Journal article; Peer reviewed, 2018)
      Background Information is needed on bleeding risk factors specific for patients with atrial fibrillation (AF) treated with non-vitamin K oral anticoagulants (NOACs). We aimed to identify risk factors in a large real-world ...
    • Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease 

      Jortveit, Jarle; Halvorsen, Sigrun; Kaldal, Anete; Pripp, Are Hugo; Govatsmark, Ragna Elise Støre; Langørgen, Jørund (Peer reviewed; Journal article, 2019)
      Background: Patients with established coronary artery disease (CAD) have an increased risk of new cardiovascular events. An underuse of secondary preventive drugs has been observed, and many patients may not attain the ...

      Contact Us | Send Feedback

      Privacy policy
      DSpace software copyright © 2002-2019  DuraSpace

      Service from  Unit
       

       

      Browse

      ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDocument TypesJournals

      My Account

      Login

      Contact Us | Send Feedback

      Privacy policy
      DSpace software copyright © 2002-2019  DuraSpace

      Service from  Unit